The use of inferior vena caval filters prior to major surgery in women with gynaecological cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 115, Issue 7, 2008, Pages 902-907

  Adib, T ^a   Belli, A ^b   McCall, J ^a   Ind, T E J ^a   Bridges, J E ^a   Shepherd, J H ^a   Barton, D P J ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Gynaecological cancer; Surgery; Vena caval filters; Venous thromboembolism

Indexed keywords

ANTINEOPLASTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL SURGERY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; METASTASIS; MORBIDITY; OUTCOME ASSESSMENT; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; RECURRENT CANCER; RISK ASSESSMENT; TREATMENT OUTCOME; UTERINE CERVIX CANCER; UTERUS CANCER; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; PULMONARY EMBOLISM; VENA CAVA FILTERS; VENOUS THROMBOEMBOLISM;

EID: 43749085946     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.01736.x     Document Type: Article

References (31)

1. Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ. Cancer and venous thromboembolism. Am Heart J 1996 132 : 850 5.
2. Butler-Manuel SA, Gould DA, Thomas SM, Carter PG, Barton DP. Thromboembolic disease as a presentation of gynaecological malignancy. Br J Obstet Gynaecol 1997 104 : 1413 15.
3. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000 18 : 3078 83.
4. Hawes J, Lohr J, Blum B, Bhati A, Bhaskaran J, Engel A. Large uterine fibroids causing mechanical obstruction of the inferior vena cava and subsequent thrombosis: a case report. Vasc Endovascular Surg 2006 40 : 425 7.
5. Murchison JT, Wylie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br J Cancer 2004 91 : 92 5.
6. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998 351 : 1077 80.
7. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998 338 : 1169 73.
8. Green KB, Silverstein RL. Hypercoagulability in cancer. Hematol Oncol Clin North Am 1996 10 : 499 530.
9. Donati MB. Cancer and thrombosis. Haemostasis 1994 24 : 128 31.
10. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000 343 : 1846 50.
11. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 2006 166 : 458 64.
12. Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006 243 : 89 95.
13. Orr JW, Kelly FJ, Roland PY. Perioperative care. In : Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G, editors. Gynecologic Cancer. Controversies in Management. Chapter 48. Philadelphia, PA : Elsevier 2004. pp 631 48.
14. Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic surgery patients. Curr Opin Obstet Gynecol 1993 5 : 73 9.
15. Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 1991 9 : 286 94.
16. Clahsen PC, van d V, Julien JP, Floiras JL, Mignolet FY. Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol 1994 12 : 1266 71.
17. Razvi K, Al-Katib M, McCall J, Barton DP. Suprarenal vena caval thrombosis and pulmonary embolism associated with a benign ovarian cyst. J Obstet Gynaecol 2002 22 : 697 8.
18. Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994 308 : 891 4.
19. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002 87 : 575 9.
20. Tateo S, Mereu L, Salamano S, Klersy C, Barone M, Spyropoulos AC, et al. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 2005 99 : 119 25.
21. von Tempelhoff GF, Heilmann L. Antithrombotic therapy in gynecologic surgery and gynecologic oncology. Hematol Oncol Clin North Am 2000 14 : 1151 69, ix.
22. von Tempelhoff GF, Dietrich M, Niemann F, Schneider D, Hommel G, Heilmann L. Blood coagulation and thrombosis in patients with ovarian malignancy. Thromb Haemost 1997 77 : 456 61.
23. Lin J, Proctor MC, Varma M, Greenfield LJ, Upchurch GR Jr., Henke PK. Factors associated with recurrent venous thromboembolism in patients with malignant disease. J Vasc Surg 2003 37 : 976 83.
24. Clarke-Pearson DL, Jelovsek FR, Creasman WT. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol 1983 61 : 87 94.
25. Miyahara T, Miyata T, Shigematsu K, Deguchi J, Kimura H, Ishii S, et al. Clinical outcome and complications of temporary inferior vena cava filter placement. J Vasc Surg 2006 44 : 620 4.
26. Streiff MB. Vena caval filters: a review for intensive care specialists. J Intensive Care Med 2003 18 : 59 79.
27. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998 338 : 409 15.
28. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992 11 : 237 48.
29. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996 86 : 353 64.
30. Klerk CP, Smorenburg SM, Otten HM, Lensing AW, Prins MH, Piovella F, et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 2005 23 : 2130 5.
31. Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 2004 22 : 1944 8.